The World Health Organisation is celebrating a breakthrough in malaria treatment after recommending the only approved vaccine for wide-scale implementation across countries in Africa.
A large scale pilot program by the WHO has seen two point three million doses of the Mosquitrix vaccine administered to babies in Malawi Ghana and Kenya since 2019.
The groundbreaking vaccine, developed in Africa by African scientists, promises to reduce fatalities related to malaria, which claimed the lives of nearly 400,000 people across the continent in 2019, making it more deadly than COVID.
While only thirty per cent effective in preventing severe cases of malaria in children, it constitutes a significant step towards fighting the spread of malaria.